Hence, this study determined blood RGS1 expression in 210 surgical NSCLC patients and 30 healthy controls (HCs), intending to explore the association of blood RGS1 with clinical characteristics and its prognostic value in NSCLC patients. Here, RGS1 is linked to non-small cell lung carcinoma.